Stock Trading at Merrimack Pharmaceuticals Inc. (MACK): J. Robert Mulroy buys 280,168 shares
Merrimack Pharmaceuticals Inc. (NASDAQ:MACK)’s President and Chief Executive Officer J. Robert Mulroy used some stock options…
Merrimack Pharmaceuticals Inc. (NASDAQ:MACK)’s President and Chief Executive Officer J. Robert Mulroy used some stock options…
After Merrimack Pharmaceuticals Inc. (NASDAQ:MACK)’s stock plummeted by over 10% yesterday, some insiders were clever…